Entero Healthcare Solutions Ltd Share Price

Trading - Medium / Small

NSE: ENTERO Small Cap ISIN: INE010601016
As on 03 January 2025 at 09:11 IST
As on 03 January 2025 at 09:11 IST
1,419.35
+ 0.00
(0.00%)
Over 1 Month
4.81%
Over 6 Months
35.53%
Over 1 Year
23.47%
Over 3 Years
0.00%

Entero Healthcare Solutions Ltd Summary

Close 1,419.35
Open 1,435.70
High 1,460.95
Low 1,414.05
Volume 13,646
Net Turnover (in ₹) 1,95,87,661.75
52 Week High 1,584.25
52 Week Low 970
52Wk High / Low
970
1,584.25

Entero Healthcare Solutions Ltd Key Financial Data

Market Cap (in ₹ Cr) 6,173.29
EPS (TTM) 17.11
Book Value (BV) 382.52
Div. Yield -
P/E (TTM) 82.82
Price/Book Value 3.70
Delivery % 47.33
Face Value 10

Entero Healthcare Solutions Ltd Key Ratios

P/E ratio 111.41
P/B ratio 2.64
EV to Sales 11.03
PEG Ratio -0.86
ROA 2.34
ROE 4.83
Debt-Equity 0.06
Net Profit Margin 12.08
Operating Profit Margin 17.42

Entero Healthcare Solutions Ltd Peer Comparison

Company LTP Market Cap (in ₹ Cr)
Entero Healthcare Solutions Ltd ₹1,417.10 ₹6,163.50
Trent Ltd ₹7,318.25 ₹2,60,154.61
Avenue Supermarts Ltd ₹3,617.75 ₹2,35,418.96
Brainbees Solutions Ltd ₹653 ₹33,902.73
Aditya Birla Fashion & Retail Ltd ₹282.55 ₹30,266.63
Redtape Ltd ₹878.95 ₹12,147.26

Entero Healthcare Solutions Ltd News

Entero Healthcare Solutions schedules board meeting

On 12 November 2024

07 Nov 2024

Entero Healthcare soars after India Ratings upgrades rating to 'A-'

Entero Healthcare Solutions surged 6.07% to Rs 1488 after India Ratings and Research upgraded the company's long-term issuer rating to 'IND A-' from 'IND BBB' with 'stable' outlook.

11 Sep 2024

Entero Healthcare Solutions to conduct board meeting

On 14 August 2024

12 Aug 2024

Entero Healthcare Solutions to hold AGM

On 28 August 2024

06 Aug 2024

Entero Healthcare Solutions to convene board meeting

On 29 May 2024

28 May 2024

Entero Healthcare Solutions Ltd Financials

Profit and Loss

Particulars (in ₹ Cr.) FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Total Revenue408.09230.26164.16128.30-
Total Expenses383.72242.71205146.45-
Profit Before Tax24.36-12.46-40.85-18.15-
Profit After Tax38.44-12.46-40.85-18.15-
Operating Profit after Depreciation46.68-1.15-35.56-15.89-

Balance Sheet

Particulars (in ₹ Cr.) FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Fixed Assets34.4440.6551.4752.43-
Total Non Current Assets107.6090.5696.8196.28-
Total Current Assets1,660.98673557.27436.43-
TOTAL ASSETS1,768.58763.57654.08532.71-
Total Shareholder's Fund1,626.41583.73551.21486.44-

Cash Flow

Particulars (in ₹ Cr.) FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Net Cash from Operating Activities-75.65-56.91-44.70-68.20-
Net Cash used in Investing Activities-762.69-58.29-68.80-7.21-
Net Cash used in Financing Activities925.5691.11127.4875.50-

Entero Healthcare Solutions Ltd Corporate Actions

No available data

About Entero Healthcare Solutions Ltd

Entero Healthcare is one of India’s largest and fastest-growing healthcare products distribution platforms. It serves as a vital link between healthcare product manufacturers and pharmacies, hospitals, and clinics. Established in 2018, Entero Healthcare’s integrated and technology-driven distribution platform ensures that healthcare products are accessible across India.

It is operating within the healthcare distribution sector. Entero Healthcare boasts a headquarters located at Unit No. 605 & 606, 6th Floor, Trade Center, Bandra Kurla Complex, Bandra East, Mumbai, Maharashtra. The company was founded by Mr. Rajesh Gupta and Mr. Anil Gupta. They continue to play a pivotal role in its management and growth.

Entero Healthcare’s product portfolio includes a wide range of pharmaceuticals, medical devices, and over-the-counter (OTC) medications. This diversified product range enables the company to meet the varying needs of the healthcare industry effectively.

Entero Healthcare is among the top three healthcare products distributors in India in terms of revenue. The promoter shareholding is mainly held at 52.44% by Prabhat Agarwal and family. The company’s registered office is also its headquarters. It works with registrars like Link Intime India Private Limited to manage its operations efficiently.

Here are the top managing promoters of the company:
  • Sujesh Vasudevan
  • Prabhat Agrawal
  • Prem Sethi
  • Rajesh Shashikant Dalal
  • Sandhya Gadkari Sharma

By leveraging technology and maintaining a robust distribution network, Entero Healthcare continues to thrive in the competitive healthcare sector. Its commitment to providing high-quality healthcare products and services has solidified its reputation as a reliable and dynamic player in the industry.

Impact of the Company

Entero Healthcare has made a significant impact on the healthcare distribution landscape in India since its start in 2018. It has leveraged technology and a robust distribution network. The company has successfully connected healthcare product manufacturers with pharmacies, hospitals, and clinics across the country. This has improved the accessibility of essential healthcare products. It has also streamlined the supply chain, ensuring timely delivery and reducing inefficiencies.

One of the key impacts of Entero Healthcare is its contribution to the growth and modernization of the healthcare distribution sector. It is providing a comprehensive and integrated platform. The company has helped bridge the gap between manufacturers and end-users. This makes it easier for healthcare providers to access a wide range of products. This has been particularly beneficial in rural and underserved areas, where access to quality healthcare products can be limited.

Entero Healthcare’s strategic acquisitions have further expanded its reach and product offerings. In May 2024, the company completed four acquisitions of healthcare distributors, adding annualized revenue of over Rs. 170 crore. These acquisitions have not only increased Entero’s market share but also enhanced its ability to serve a broader customer base more effectively. This expansion has positioned Entero Healthcare as one of the top three healthcare products distributors in India in terms of revenue.

The company’s focus on technology-driven solutions has also had a positive impact on the healthcare industry. It has implementing advanced systems for inventory management, order processing, and logistics. Entero Healthcare has improved the efficiency and reliability of the distribution process. This has led to better inventory control, reduced wastage, and improved overall customer satisfaction.

Entero Healthcare’s commitment to quality and innovation has earned it a strong reputation in the industry. The company’s diversified product range, which includes pharmaceuticals, medical devices, and over-the-counter medications. This ensures that it can meet the varying needs of healthcare providers. This has made Entero a preferred partner for many manufacturers and distributors, further solidifying its position in the market.

Entero Healthcare’s role in the healthcare sector extends beyond mere distribution. The company’s ability to adapt to the dynamic market conditions and its commitment to innovation have positioned it as a key player in the industry. It ensuring that healthcare products are delivered promptly and efficiently across the country.

Moreover, Entero Healthcare’s strategic partnerships and collaborations with leading pharmaceutical companies and healthcare providers have further strengthened its market position. These alliances have enabled the company to offer a comprehensive range of products. It has catering to the diverse needs of the healthcare sector. The company’s focus on maintaining high standards of quality and compliance has also earned it the trust and loyalty of its clients.

In addition to its operational achievements, Entero Healthcare is committed to corporate social responsibility. The company actively engages in initiatives aimed at promoting health awareness and education. It also aims at supporting various community programs, and contributing to the overall well-being of society. Through these efforts, Entero Healthcare not only enhances its corporate image but also makes a meaningful difference in the lives of people.

Entero Healthcare’s impact on the healthcare distribution sector in India has been profound. Through strategic acquisitions, technological advancements, and a commitment to quality, the company has transformed the way healthcare products are distributed and accessed. Its efforts have not only improved the efficiency of the supply chain but also contributed to the overall growth and modernization of the healthcare industry. As Entero Healthcare continues to expand its reach and enhance its services, its influence on the sector is expected to grow even further.

Entero Healthcare Solutions Ltd Stock Analysis

  1. Annual revenue for Entero Healthcare Solutions Ltd increased by 77.23% to ₹408.09 crore in FY 2024 from ₹230.26 crore in FY 2023.
  2. Annual Net Profit for Entero Healthcare Solutions Ltd decreased by 408.63% to ₹38.44 crore in FY 2024 from ₹-12.46 crore in FY 2023.
  3. Promoter Shareholding in Entero Healthcare Solutions Ltd remains unchanged by 0.00% in the most recent quarter, from 52.44% in June 2024 to 52.44% in September 2024.
  4. Entero Healthcare Solutions Ltd delivered a 1-year return of 23.47% compared to the Nifty 50, which provided a return of 11.64% as of the last trading session.
  5. Entero Healthcare Solutions Ltd share price moved remains unchanged by 0.00% from its previous close of INR ₹1,419.35. The latest Entero Healthcare Solutions Ltd share price is INR ₹1,419.35.
  6. Entero Healthcare Solutions Ltd share price today has been at a low of 1,414.05 and a high of 1,460.95. Over the past 52 weeks, the Entero Healthcare Solutions Ltd share price has seen a low of 970 and a high of 1,584.25.

FAQ’s

What is the share price of Entero Healthcare Solutions Ltd today?

Entero Healthcare Solutions Ltd share price as on 3 Jan 2025 is ₹ 1419.35

What is the Market Cap of Entero Healthcare Solutions Ltd?

The market cap of Entero Healthcare Solutions Ltd stock is ₹6,173.29 Cr.

What is the PE Ratio of Entero Healthcare Solutions Ltd?

The Price to Earnings (P/E) Ratio of Entero Healthcare Solutions Ltd is 111.41

What is the PB Ratio of Entero Healthcare Solutions Ltd?

The Price to Book (P/B) Ratio of Entero Healthcare Solutions Ltd is 2.64

What is the 52 week high of Entero Healthcare Solutions Ltd Share Price?

The 52 week high of Entero Healthcare Solutions Ltd share price stands at ₹1,584.25

What is the 52 week low of Entero Healthcare Solutions Ltd Share Price?

The 52 week low of Entero Healthcare Solutions Ltd share price stands at ₹970

Get started with us today and
start building your wealth journey